PKC-δ mediates interferon-α-induced apoptosis through c-Jun NH 2-terminal kinase activation

BMC Cell Biology

Volumn 13, Issue , 2012, Pages

  Yanase, Noriko ^a   Hayashida, Miho ^a,b   Kanetaka Naka, Yuki ^a,b   Hoshika, Akinori ^b   Mizuguchi, Junichiro ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Apoptosis; B lymphoma cells; Interferon ; JNKs; PKC

Indexed keywords

INTERFERON; MUTANT PROTEIN; PROPIDIUM IODIDE; PROTEIN KINASE C DELTA; ROTTLERIN; STAT1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; ALPHA INTERFERON;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MITOCHONDRIAL MEMBRANE POTENTIAL; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; UPREGULATION; WESTERN BLOTTING; B CELL LYMPHOMA; ENZYMOLOGY; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PROMOTER REGION; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; ENZYME ACTIVATION; HUMANS; INTERFERON-ALPHA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHOMA, B-CELL; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C-DELTA; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84858591591     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-13-7     Document Type: Article

References (48)

1. Gutterman JU. Cytokine therapeutics: lessons from interferon alpha. Proc Natl Acad Sci USA 1994, 91:1198-1205. 10.1073/pnas.91.4.1198, 43124, 8108387.
2. Gresser I. Wherefore interferon?. J Leukoc Biol 1997, 61:567-574.
3. Sangfelt O, Erickson S, Castro J, Heiden T, Einhorn S, Grander D. Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines. Cell Growth Differ 1997, 8:343-352.
4. Yanase N, Takada E, Yoshihama I, Ikegami H, Mizuguchi J. Participation of Bax-alpha in IFN-alpha-mediated apoptosis in Daudi B lymphoma cells. J Interferon Cytokine Res 1998, 18:855-861. 10.1089/jir.1998.18.855, 9809621.
5. Caraglia M, Abbruzzese A, Leardi A, Pepe S, Budillon A, Baldassare G, Selleri C, Lorenzo SD, Fabbrocini A, Giuberti G, Vitale G, Lupoli G, Bianco AR, Tagliaferri P. Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor. Cell Death Differ 1999, 6:773-780. 10.1038/sj.cdd.4400550, 10467351.
6. Grander D. How does interferon-alpha exert its antitumour activity in multiple myeloma?. Acta Oncol 2000, 39:801-805. 10.1080/028418600750063532, 11145436.
7. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998, 67:227-264. 10.1146/annurev.biochem.67.1.227, 9759489.
8. Kotenko SV, Pestka S. Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 2000, 19:2557-2565. 10.1038/sj.onc.1203524, 10851054.
9. David M, Petricoin E, Benjamin C, Pine R, Weber MJ, Larner AC. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science 1995, 269:1721-1723. 10.1126/science.7569900, 7569900.
10. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40. 10.1038/35065000, 11242034.
11. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005, 5:375-386. 10.1038/nri1604, 15864272.
12. Yanase N, Hata K, Shimo K, Hayashida M, Evers BM, Mizuguchi J. Requirement of c-Jun NH2-terminal kinase activation in interferon-alpha-induced apoptosis through upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells. Exp Cell Res 2005, 310:10-21. 10.1016/j.yexcr.2005.06.021, 16099454.
13. Goh KC, Haque SJ, Williams BR. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J 1999, 18:5601-5608. 10.1093/emboj/18.20.5601, 1171628, 10523304.
14. Mayer IA, Verma A, Grumbach IM, Uddin S, Lekmine F, Ravandi F, Majchrzak B, Fujita S, Fish EN, Platanias LC. The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells. J Biol Chem 2001, 276:28570-28577. 10.1074/jbc.M011685200, 11353767.
15. Brodie C, Blumberg PM. Regulation of cell apoptosis by protein kinase c delta. Apoptosis 2003, 8:19-27. 10.1023/A:1021640817208, 12510148.
16. Ohno S, Nishizuka Y. Protein kinase C isotypes and their specific functions: prologue. J Biochem (Tokyo) 2002, 132:509-511.
17. Spitaler M, Cantrell DA. Protein kinase C and beyond. Nat Immunol 2004, 5:785-790. 10.1038/ni1097, 15282562.
18. Yoshida K, Miki Y, Kufe D. Activation of SAPK/JNK signaling by protein kinase Cdelta in response to DNA damage. J Biol Chem 2002, 277:48372-48378. 10.1074/jbc.M205485200, 12377781.
19. Uddin S, Sassano A, Deb DK, Verma A, Majchrzak B, Rahman A, Malik AB, Fish EN, Platanias LC. Protein kinase C-delta (PKC-delta) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem 2002, 277:14408-14416. 10.1074/jbc.M109671200, 11839738.
20. Mitsutake N, Namba H, Shklyaev SS, Tsukazaki T, Ohtsuru A, Ohba M, Kuroki T, Ayabe H, Yamashita S. PKC delta mediates ionizing radiation-induced activation of c-Jun NH(2)-terminal kinase through MKK7 in human thyroid cells. Oncogene 2001, 20:989-996. 10.1038/sj.onc.1204179, 11314034.
21. Kaur S, Parmar S, Smith J, Katsoulidis E, Li Y, Sassano A, Majchrzak B, Uddin S, Tallman MS, Fish EN, Platanias LC. Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cells. Exp Hematol 2005, 33:550-557. 10.1016/j.exphem.2005.01.014, 15850832.
22. Jackson DN, Foster DA. The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival. FASEB J 2004, 18:627-636. 10.1096/fj.03-0979rev, 15054085.
23. Saijo K, Mecklenbrauker I, Schmedt C, Tarakhovsky A. B cell immunity regulated by the protein kinase C family. Ann N Y Acad Sci 2003, 987:125-134. 10.1111/j.1749-6632.2003.tb06040.x, 12727631.
24. Soltoff SP. Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cdelta tyrosine phosphorylation. J Biol Chem 2001, 276:37986-37992.
25. DeVries TA, Kalkofen RL, Matassa AA, Reyland ME. Protein kinase Cdelta regulates apoptosis via activation of STAT1. J Biol Chem 2004, 279:45603-45612. 10.1074/jbc.M407448200, 15322115.
26. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001, 14:778-809. table of contents, 10.1128/CMR.14.4.778-809.2001, 89003, 11585785.
27. Stetson DB, Medzhitov R. Type I interferons in host defense. Immunity 2006, 25:373-381. 10.1016/j.immuni.2006.08.007, 16979569.
28. Barber GN. Host defense, viruses and apoptosis. Cell Death Differ 2001, 8:113-126. 10.1038/sj.cdd.4400823, 11313713.
29. Le Page C, Genin P, Baines MG, Hiscott J. Interferon activation and innate immunity. Rev Immunogenet 2000, 2:374-386.
30. Kanetaka Y, Hayashida M, Hoshika A, Yanase N, Mizuguchi J. Interferon-alpha induces transient upregulation of c-FLIP through NF-kappaB activation. Exp Cell Res 2008, 314:246-254. 10.1016/j.yexcr.2007.10.001, 17988665.
31. Hersey P, Zhang XD. How melanoma cells evade trail-induced apoptosis. Nature Rev Cancer 2001, 1:142-150.
32. Liao YF, Hung YC, Chang WH, Tsay GJ, Hour TC, Hung HC, Liu GY. The PKC delta inhibitor, rottlerin, induces apoptosis of haematopoietic cell lines through mitochondrial membrane depolarization and caspases' cascade. Life Sci 2005, 77:707-719. 10.1016/j.lfs.2005.01.010, 15922001.
33. Ndebele K, Gona P, Jin TG, Benhaga N, Chalah A, Degli-Esposti M, Khosravi-Far R. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced mitochondrial pathway to apoptosis and caspase activation is potentiated by phospholipid scramblase-3. Apoptosis 2008, 13:845-856. 10.1007/s10495-008-0219-4, 2941895, 18491232.
34. Yanase N, Ohshima K, Ikegami H, Mizuguchi J. Cytochrome c release, mitochondrial membrane depolarization, caspase-3 activation, and Bax-alpha cleavage during IFN-alpha-induced apoptosis in Daudi B lymphoma cells. J Interferon Cytokine Res 2000, 20:1121-1129. 10.1089/107999000750053799, 11152579.
35. Toyota H, Yanase N, Yoshimoto T, Moriyama M, Sudo T, Mizuguchi J. Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax. Cancer Lett 2003, 189:221-230. 10.1016/S0304-3835(02)00552-9, 12490315.
36. Yanase N, Kanetaka Y, Mizuguchi J. Interferon-alpha-induced apoptosis via tumor necrosis factor-inducing ligand (TRAIL)-dependent and -independent manner. Oncol Rep 2007, 18:1031-1038.
37. Sato K, Hida S, Takayanagi H, Yokochi T, Kayagaki N, Takeda K, Yagita H, Okumura K, Tanaka N, Taniguchi T, Ogasawara K. Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta. Eur J Immunol 2001, 31:3138-3146. 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B, 11745330.
38. Wang Q, Ji Y, Wang X, Evers BM. Isolation and molecular characterization of the 5'-upstream region of the human TRAIL gene. Biochem Biophys Res Commun 2000, 276:466-471. 10.1006/bbrc.2000.3512, 11027498.
39. Gong B, Almasan A. Genomic organization and transcriptional regulation of human Apo2/TRAIL gene. Biochem Biophys Res Commun 2000, 278:747-752. 10.1006/bbrc.2000.3872, 11095979.
40. Kumar A, Commane M, Flickinger TW, Horvath CM, Stark GR. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 1997, 278:1630-1632. 10.1126/science.278.5343.1630, 9374464.
41. Terui K, Haga S, Enosawa S, Ohnuma N, Ozaki M. Hypoxia/re-oxygenation-induced, redox-dependent activation of STAT1 (signal transducer and activator of transcription 1) confers resistance to apoptotic cell death via hsp70 induction. Biochem J 2004, 380:203-209. 10.1042/BJ20031891, 1224164, 14984365.
42. Timofeeva OA, Plisov S, Evseev AA, Peng S, Jose-Kampfner M, Lovvorn HN, Dome JS, Perantoni AO. Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis. Oncogene 2006, 25:7555-7564. 10.1038/sj.onc.1209742, 16799645.
43. Kaul S, Anantharam V, Yang Y, Choi CJ, Kanthasamy A, Kanthasamy AG. Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells. J Biol Chem 2005, 280:28721-28730. 10.1074/jbc.M501092200, 15961393.
44. Joseloff E, Cataisson C, Aamodt H, Ocheni H, Blumberg P, Kraker AJ, Yuspa SH. Src family kinases phosphorylate protein kinase C delta on tyrosine residues and modify the neoplastic phenotype of skin keratinocytes. J Biol Chem 2002, 277:12318-12323. 10.1074/jbc.M111618200, 11812791.
45. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998, 281:2042-2045.
46. Bracci L, Proietti E, Belardelli F. IFN-alpha and novel strategies of combination therapy for cancer. Ann N Y Acad Sci 2007, 1112:256-268. 10.1196/annals.1415.030, 17567945.
47. Cooper MR. A review of the clinical studies of alpha-interferon in the management of multiple myeloma. Semin Oncol 1991, 18:18-29.
48. Hirai S, Izumi Y, Higa K, Kaibuchi K, Mizuno K, Osada S, Suzuki K, Ohno S. Ras-dependent signal transduction is indispensable but not sufficient for the activation of AP1/Jun by PKC delta. EMBO J 1994, 13:2331-2340. 395098, 8194525.